Loading…
Based on limited metadata, International Trading Pharm Lab Inc, a pharmaceutical manufacturer, received an FDA Warning Letter on April 24, 2020, regarding drug products. Without access to the complete letter text or detailed subject information, the specific manufacturing or compliance violations cannot be definitively determined; however, the warning indicates the company failed to meet FDA regulatory standards for drug production or distribution. The FDA's issuance of this letter suggests the agency identified serious deficiencies requiring immediate corrective action to bring operations into compliance with federal drug regulations.